17424
EPI-001 is being developed by the pharmaceutical company ESSA Pharma Inc ( Vancouver , Canada ) for the treatment of castration-resistant prostate cancer and is currently in pre-clinical development .
 None
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: location, person, organization 
Text: {0} 
 Entities:  
Answer:
 None